Ohio Senate Weighs Stricter Prescription Drug Rules
House Bill 324 would require in-person exams and follow-up visits for medications with severe side effects in more than 5% of users.
Updated on Nov. 13, 2026 in Legislative Policy

Live Poll
Should Ohio require in-person doctor exams before risky prescription medications?
The Ohio Senate is considering House Bill 324, the Patient Protection Act, which passed the Ohio House in November 2025. The bill targets prescription drugs with one or more severe adverse effects in more than 5% of users.
Why it matters
The legislation would set uniform requirements for providers prescribing targeted medications across Ohio, including in rural areas served by hospitals such as those in southeast Ohio. Its sponsors say it aims to help Ohioans avoid dangerous drugs and unfortunate side effects.
House Bill 324 sets a 5% threshold for severe adverse effects, a figure chosen following Food and Drug Administration and other medical requirements. The bill would require all three provisions, an in-person examination, side-effect notification, and a scheduled follow-up, before a patient begins a targeted medication.
The players
Adam Mathews
Mathews is an Ohio state representative for House District 56 and the primary sponsor of House Bill 324.
Memorial Health System
Memorial Health System is a healthcare provider serving roughly 350,000 patients in southeast Ohio and West Virginia.
The details
The bill requires providers to notify patients of side effects and their severity and to schedule a follow-up appointment. Sponsor Adam Mathews, who represents Ohio House District 56, said the bill would ensure all providers give the same level of care by codifying regulations, and that it would not impose further barriers on rural patients.
Timeline
November 2025: The Ohio House of Representatives passed House Bill 324.
November 13, 2026: The bill was under consideration in the Ohio Senate.
Political Context
The bill's 5% threshold draws on Food and Drug Administration and other medical requirements, extending federal drug-safety standards into Ohio's prescribing rules. Critics have raised concerns that telehealth and women's health services could be unfairly targeted, concerns the bill's sponsors dispute.
If passed, patients in Ohio would need an in-person examination before starting a targeted prescription and would have to schedule a follow-up appointment. Patients would also receive written notice of each side effect and its severity before treatment begins.
The takeaway
House Bill 324 would give Ohio patients clearer warnings and required check-ins before starting medications with serious risks. Whether those safeguards take effect depends on the Senate's action on the bill.
Further reading
For more on how state lawmakers shape health rules, see Legislative Policy coverage across Ohio.
Source note: This article includes information reported by What to know about Ohio's 2nd District primary winners - The Post.
Live Poll
Should Ohio require in-person doctor exams before risky prescription medications?










